Can Mid-Cap Lantheus Continue its 2022 Outperformance?

Mid-cap Lantheus Holdings (NASDAQ: LNTH) has been on a revenue growth spurt in recent quarters, boosted by a new product called Pylarify, which helps medical professionals detect prostate cancer through imaging tests.  MarketBeat.com – MarketBeat Lantheus went public in June 2015, which means that it’s new enough to be in that zone where stocks often…

The One Question that Matters for Altria Stock

Altria (NYSE:MO) stock is essentially flat after the company reported a miss in both revenue and earnings in its quarterly earnings report. The company delivered revenue of $5.41 billion which was shy of analysts’ estimates for $5.59 billion. Earnings were a narrower miss, with Altria posting $1.28 earnings per share (EPS). Analysts were forecasting EPS…

Adidas Took Too Long to Drop Kanye West. A Behavioral Economist Reveals 3 Mental Blindspots That Could Explain The Company’s Failed Response.

Opinions expressed by Entrepreneur contributors are their own. “Adidas does not tolerate antisemitism and any other sort of hate speech… the company has taken the decision to terminate the partnership with Ye immediately,” according to its October 25 news release. That statement conveys a principled and admirable stance against the antisemitism shown by the rapper…